DMARDs Flashcards
What is more effective: methotrexate + etanercept or Methotrexate+sulfasalazine+hydroxychloroquine?
no difference between triple non-biologic therapy and biologic treatment. Evidence shows you can go with the cheaper, triple therapy option
What is mechanism of Methotrexate?
immunosuppression by inhibition of AICAR transformylase, which increases AICA riboside, which inhibits adensoine deaminase, resulting in increased adenosine, resulting in lymphocyte prolif inhibition and IL-1,TNF, and INFg suppression. Increases IL-4 and impairs release of histamine and neutrophil chemotaxis.
What effect does AICAR transformylase have on AICA?
it reduces AICA levels normally
What is the relationship between AICA levels and RA?
high AICA levels correlate with decreased RA symptoms. Methotrexate increases AICA by inhibiting AICAR
How does methotrexate stay in cells?
it undergoes polyglutamation as soon as it enters cells.
Adverse effects of methotrexate?
susceptibility to disease and neoplasm. Teratogen, and pulmonary toxicity. Severe GI toxicity and PUD/ulcerative colitis possible when given with NSAIDs
What is MOA of sulfasalazine?
metabolized to active sulfapyridine and mesalamine by bacteria in colon. Mesalamine is anti-inflammatory and inhibits PG and LT production.
Adverse effects of sulfasalazine?
potentially fatal blood dyscrasias
What is MOA of leflunomide?
active metabolite is A77 1726 which inhibits DHODH (dihydroorotate dehydrogenase, which normally catalyzes de novo pyrimidine synthesis. Without it, T and B lymphocytes enter arrested cell cycles and Ig production is halted.
Adverse effects of leflunomide?
hepatotoxicity with chronic use.
What is MOA of hydroxychloroquine?
anti-malarial, increases intracellular vacuole pH and alres processes like protein degradation by acidic hydrolases in lysosomes. Antigenic proteins can not be digested and presented on MHC class II proteins, this inhibits CD4 stimulation.
Contraindications of hydroxychloroquine?
can not give in ocular disease because drug causes corneal opacities
MOA of abatacept?
human CTLA4/IgG1 Fc fragment that binds CD80 and CD86 to prevent T cell co-stim signal from engaging with CD28
MOA of adalimumab?
TNF-a monoclonal antibody that binds TNF-alpha and blocks its interaction with the p55 and p75 cell surface receptors
MOA of anakinra?
recombinant human IL-1Ra (receptor antagonist) that competitively inhibits IL-1a and IL1-b binding to IL-1R1